Panacea Biotec Limited (NSE:PANACEABIO)
India
· Delayed Price · Currency is INR 522.95
+24.90 (5.00%)
Apr 17, 2025, 3:30 PM IST
Panacea Biotec Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Net Income | - | -11.73 | -332.37 | 10,783 | -1,477 | -1,943 | Upgrade
|
| Depreciation & Amortization | - | 367.11 | 391.23 | 430.34 | 447.76 | 432.19 | Upgrade
|
| Other Amortization | - | - | - | 7.43 | 8.18 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 45.59 | -22.99 | -0.07 | 0.38 | 290.16 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 15.75 | 42.63 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.72 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | - | -0.77 | -3.32 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 11.09 | 23.87 | 8.98 | 23.29 | 184.74 | Upgrade
|
| Other Operating Activities | - | -509.95 | -915.15 | -15,339 | 1,807 | 1,762 | Upgrade
|
| Change in Accounts Receivable | - | 29.56 | 68.94 | -463.4 | -168.57 | 201.14 | Upgrade
|
| Change in Inventory | - | 241.58 | 106.3 | -385.8 | -264.45 | -662.64 | Upgrade
|
| Change in Accounts Payable | - | - | - | - | - | -496.89 | Upgrade
|
| Change in Other Net Operating Assets | - | -174.25 | -3,544 | 3,858 | 652.1 | -16.57 | Upgrade
|
| Operating Cash Flow | - | -1 | -4,225 | -1,084 | 1,067 | -302.27 | Upgrade
|
| Capital Expenditures | - | -777.18 | -409.46 | -125.1 | -217.63 | -69.11 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 66.83 | 395.05 | 20 | 42.56 | 161.05 | Upgrade
|
| Divestitures | - | - | - | 18,220 | - | - | Upgrade
|
| Investment in Securities | - | 728.81 | 4,197 | -5,322 | -336.03 | -452.21 | Upgrade
|
| Other Investing Activities | - | 83.81 | 120.62 | 32.8 | 34.31 | 52.67 | Upgrade
|
| Investing Cash Flow | - | 102.27 | 4,303 | 12,826 | -476.79 | -347.6 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 2.96 | 1,012 | 7,430 | Upgrade
|
| Total Debt Issued | - | - | - | 2.96 | 1,012 | 7,430 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -35.68 | -658.17 | Upgrade
|
| Long-Term Debt Repaid | - | -2.36 | -147.74 | -7,864 | -453.46 | -5,734 | Upgrade
|
| Total Debt Repaid | - | -2.36 | -147.74 | -7,864 | -489.14 | -6,392 | Upgrade
|
| Net Debt Issued (Repaid) | - | -2.36 | -147.74 | -7,861 | 522.86 | 1,038 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 320 | Upgrade
|
| Other Financing Activities | - | -25.72 | -35.99 | -3,898 | -993.96 | -450.54 | Upgrade
|
| Financing Cash Flow | - | -28.08 | -183.73 | -11,759 | -471.1 | 907.39 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.03 | -0.04 | -0.13 | - | - | Upgrade
|
| Net Cash Flow | - | 73.22 | -104.98 | -17.42 | 118.61 | 257.52 | Upgrade
|
| Free Cash Flow | - | -778.18 | -4,634 | -1,210 | 848.87 | -371.38 | Upgrade
|
| Free Cash Flow Margin | - | -13.92% | -100.75% | -18.29% | 13.59% | -6.83% | Upgrade
|
| Free Cash Flow Per Share | - | -12.71 | -75.66 | -19.75 | 13.86 | -6.06 | Upgrade
|
| Cash Interest Paid | - | 25.72 | 35.99 | 3,898 | 993.96 | 450.25 | Upgrade
|
| Cash Income Tax Paid | - | 25.06 | 24.77 | 4,037 | 9.95 | 86.74 | Upgrade
|
| Levered Free Cash Flow | - | -651.53 | -4,293 | 2,811 | 1,882 | -1,978 | Upgrade
|
| Unlevered Free Cash Flow | - | -634.82 | -4,269 | 3,935 | 3,037 | -895.97 | Upgrade
|
| Change in Net Working Capital | - | -34.43 | 3,609 | -3,925 | -2,531 | 1,527 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.